Impact of Vitamin B12 Replacement on Epogen Dosing & Improvement of

Status Completed

Clinical Trial Summary

Vitamin B12 has several important functions in the body, two of which are production of red blood cells and the maintenance of a healthy nervous system. When vitamin B12 is deficient, abnormal red blood cells form. These cells are called megaloblasts. The end result is a decreased number of red blood cells; a condition called anemia. Some symptoms of anemia include fatigue, weakness, shortness of breath, and pallor. Vitamin B12 is also important in maintaining a healthy nervous system. Nerves are surrounded by an insulating material that helps them conduct impulses. Patients with low B12 levels who receive this vitamin in injection form, state that there quality of life is better. Anemia in Hemodialysis patients is treated with Epogen, a synthetic material which helps your body make blood cells. The investigators believe that if you have a low vitamin B12 level in your blood and the investigators give you the vitamin during dialysis your requirement for epogen will be lower and you will be able to produce blood cells better. When evaluating for Vitamin B12 deficiency a special test is needed called methylmalonic acid level (MMA). This is a blood test that will be performed and when this level is high and your vitamin B12 level is in the low normal range the investigators can make a diagnosis of vitamin B12 deficiency.

Clinical Trial Description

BACKGROUND: Vitamin B12 deficiency may have deleterious effects on end stage renal disease (ESRD) patients on maintenance hemodialysis, and may increase erythropoietin stimulating agent (ESA) resistance, yet little is known about its prevalence in this population.

METHODS: Serum vitamin B12 and methylmalonic acid (MMA) levels were drawn from ESRD patients prior to hemodialysis. All patients with MMA levels greater than 800 nmol/L had peripheral smears evaluated for B12 deficiency. Those with confirmatory smears were considered to be deficient and received intramuscular vitamin B12 injections for 4 months. Post-treatment MMA levels and smears were obtained. Erythropoietin dosages were monitored throughout the treatment period. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01876732
Study type	Interventional
Source	Northwell Health
Contact
Status	Completed
Phase	N/A
Start date	June 2009
Completion date	April 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02270749` - Vitamin Deficiencies and Suppletion in Morbid Obesity	Phase 4
Completed	`NCT02540642` - Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients	N/A
Completed	`NCT00826657` - Vitamin B12 Supplementation Study	N/A
Completed	`NCT00843453` - Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly	N/A
Completed	`NCT01584050` - Relative Bioavailability of Folic Acid and L-5-Methlytetrahydrofolate	N/A
Completed	`NCT01661309` - Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial	N/A
Completed	`NCT01876329` - Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients	N/A
Active, not recruiting	`NCT00326833` - How Many Patients Are in Need of Vitamin B12 Injections?	Phase 4
Completed	`NCT00467623` - Holotranscobalamin Remains Unchanged During Pregnancy	N/A
Completed	`NCT02076347` - Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin	N/A
Completed	`NCT01297361` - The Association Between Religious Origin and Age, and Vitamin B12 and Folic Acid Plasma Levels in Non Jewish Population in Western Galilee	N/A
Completed	`NCT01136512` - Metformin Use and Vitamin B12 Deficiency	N/A
Active, not recruiting	`NCT04048330` - Periconceptional Surveillance in India
Completed	`NCT00699478` - Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy	Phase 2
Completed	`NCT00279552` - Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms